Global Peripheral Arterial Disease (PAD) Therapeutics Market Size, Status and Forecast 2020-2026


Peripheral Arterial Disease (PAD) Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Peripheral Arterial Disease (PAD) Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
    AstraZeneca Plc. (UK)
    Bayer HealthCare Pharmaceuticals (Germany)
    Bristol-Myers Squibb Company (US)
    Merck & Co., Inc. (US)
    Proteon Therapeutics, Inc. (US)
    Sanofi S.A. (France)
    Symic Bio, Inc. (US)
    TheraVasc Inc. (US)
    AnGes MG, Inc. (Japan)
    Athersys, Inc. (US)
    Betagenon AB (Sweden)
    miRagen Therapeutics, Inc. (US)
    Multi Gene Vascular Systems Ltd (Israel)
    ViroMed Co. Ltd. (Korea)

Market segment by Type, the product can be split into
    Anti-Platelet Drugs
    Dual Antiplatelet Therapy Drugs
    Others
Market segment by Application, split into
    Hospitals
    Clinics
    Others

Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America
1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered: Ranking by Peripheral Arterial Disease (PAD) Therapeutics Revenue
    1.4 Market by Type
        1.4.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
        1.4.2 Anti-Platelet Drugs
        1.4.3 Dual Antiplatelet Therapy Drugs
        1.4.4 Others
    1.5 Market by Application
        1.5.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application: 2020 VS 2026
        1.5.2 Hospitals
        1.5.3 Clinics
        1.5.4 Others
    1.6 Study Objectives
    1.7 Years Considered

2 Global Growth Trends
    2.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Perspective (2015-2026)
    2.2 Global Peripheral Arterial Disease (PAD) Therapeutics Growth Trends by Regions
        2.2.1 Peripheral Arterial Disease (PAD) Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
        2.2.2 Peripheral Arterial Disease (PAD) Therapeutics Historic Market Share by Regions (2015-2020)
        2.2.3 Peripheral Arterial Disease (PAD) Therapeutics Forecasted Market Size by Regions (2021-2026)
    2.3 Industry Trends and Growth Strategy
        2.3.1 Market Top Trends
        2.3.2 Market Drivers
        2.3.3 Market Challenges
        2.3.4 Portera??s Five Forces Analysis
        2.3.5 Peripheral Arterial Disease (PAD) Therapeutics Market Growth Strategy
        2.3.6 Primary Interviews with Key Peripheral Arterial Disease (PAD) Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players
    3.1 Global Top Peripheral Arterial Disease (PAD) Therapeutics Players by Market Size
        3.1.1 Global Top Peripheral Arterial Disease (PAD) Therapeutics Players by Revenue (2015-2020)
        3.1.2 Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Players (2015-2020)
        3.1.3 Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Concentration Ratio
        3.2.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.2.2 Global Top 10 and Top 5 Companies by Peripheral Arterial Disease (PAD) Therapeutics Revenue in 2019
    3.3 Peripheral Arterial Disease (PAD) Therapeutics Key Players Head office and Area Served
    3.4 Key Players Peripheral Arterial Disease (PAD) Therapeutics Product Solution and Service
    3.5 Date of Enter into Peripheral Arterial Disease (PAD) Therapeutics Market
    3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
    4.1 Global Peripheral Arterial Disease (PAD) Therapeutics Historic Market Size by Type (2015-2020)
    4.2 Global Peripheral Arterial Disease (PAD) Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
    5.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2015-2020)
    5.2 Global Peripheral Arterial Disease (PAD) Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America
    6.1 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size (2015-2020)
    6.2 Peripheral Arterial Disease (PAD) Therapeutics Key Players in North America (2019-2020)
    6.3 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2015-2020)
    6.4 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2015-2020)

7 Europe
    7.1 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size (2015-2020)
    7.2 Peripheral Arterial Disease (PAD) Therapeutics Key Players in Europe (2019-2020)
    7.3 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2015-2020)
    7.4 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2015-2020)

8 China
    8.1 China Peripheral Arterial Disease (PAD) Therapeutics Market Size (2015-2020)
    8.2 Peripheral Arterial Disease (PAD) Therapeutics Key Players in China (2019-2020)
    8.3 China Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2015-2020)
    8.4 China Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2015-2020)

9 Japan
    9.1 Japan Peripheral Arterial Disease (PAD) Therapeutics Market Size (2015-2020)
    9.2 Peripheral Arterial Disease (PAD) Therapeutics Key Players in Japan (2019-2020)
    9.3 Japan Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2015-2020)
    9.4 Japan Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia
    10.1 Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Size (2015-2020)
    10.2 Peripheral Arterial Disease (PAD) Therapeutics Key Players in Southeast Asia (2019-2020)
    10.3 Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2015-2020)
    10.4 Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2015-2020)

11 India
    11.1 India Peripheral Arterial Disease (PAD) Therapeutics Market Size (2015-2020)
    11.2 Peripheral Arterial Disease (PAD) Therapeutics Key Players in India (2019-2020)
    11.3 India Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2015-2020)
    11.4 India Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2015-2020)

12 Central & South America
    12.1 Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Size (2015-2020)
    12.2 Peripheral Arterial Disease (PAD) Therapeutics Key Players in Central & South America (2019-2020)
    12.3 Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2015-2020)
    12.4 Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles
    13.1 AstraZeneca Plc. (UK)
        13.1.1 AstraZeneca Plc. (UK) Company Details
        13.1.2 AstraZeneca Plc. (UK) Business Overview
        13.1.3 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Introduction
        13.1.4 AstraZeneca Plc. (UK) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020))
        13.1.5 AstraZeneca Plc. (UK) Recent Development
    13.2 Bayer HealthCare Pharmaceuticals (Germany)
        13.2.1 Bayer HealthCare Pharmaceuticals (Germany) Company Details
        13.2.2 Bayer HealthCare Pharmaceuticals (Germany) Business Overview
        13.2.3 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Introduction
        13.2.4 Bayer HealthCare Pharmaceuticals (Germany) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020)
        13.2.5 Bayer HealthCare Pharmaceuticals (Germany) Recent Development
    13.3 Bristol-Myers Squibb Company (US)
        13.3.1 Bristol-Myers Squibb Company (US) Company Details
        13.3.2 Bristol-Myers Squibb Company (US) Business Overview
        13.3.3 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Introduction
        13.3.4 Bristol-Myers Squibb Company (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020)
        13.3.5 Bristol-Myers Squibb Company (US) Recent Development
    13.4 Merck & Co., Inc. (US)
        13.4.1 Merck & Co., Inc. (US) Company Details
        13.4.2 Merck & Co., Inc. (US) Business Overview
        13.4.3 Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Introduction
        13.4.4 Merck & Co., Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020)
        13.4.5 Merck & Co., Inc. (US) Recent Development
    13.5 Proteon Therapeutics, Inc. (US)
        13.5.1 Proteon Therapeutics, Inc. (US) Company Details
        13.5.2 Proteon Therapeutics, Inc. (US) Business Overview
        13.5.3 Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Introduction
        13.5.4 Proteon Therapeutics, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020)
        13.5.5 Proteon Therapeutics, Inc. (US) Recent Development
    13.6 Sanofi S.A. (France)
        13.6.1 Sanofi S.A. (France) Company Details
        13.6.2 Sanofi S.A. (France) Business Overview
        13.6.3 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Introduction
        13.6.4 Sanofi S.A. (France) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020)
        13.6.5 Sanofi S.A. (France) Recent Development
    13.7 Symic Bio, Inc. (US)
        13.7.1 Symic Bio, Inc. (US) Company Details
        13.7.2 Symic Bio, Inc. (US) Business Overview
        13.7.3 Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Introduction
        13.7.4 Symic Bio, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020)
        13.7.5 Symic Bio, Inc. (US) Recent Development
    13.8 TheraVasc Inc. (US)
        13.8.1 TheraVasc Inc. (US) Company Details
        13.8.2 TheraVasc Inc. (US) Business Overview
        13.8.3 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Introduction
        13.8.4 TheraVasc Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020)
        13.8.5 TheraVasc Inc. (US) Recent Development
    13.9 AnGes MG, Inc. (Japan)
        13.9.1 AnGes MG, Inc. (Japan) Company Details
        13.9.2 AnGes MG, Inc. (Japan) Business Overview
        13.9.3 AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Introduction
        13.9.4 AnGes MG, Inc. (Japan) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020)
        13.9.5 AnGes MG, Inc. (Japan) Recent Development
    13.10 Athersys, Inc. (US)
        13.10.1 Athersys, Inc. (US) Company Details
        13.10.2 Athersys, Inc. (US) Business Overview
        13.10.3 Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Introduction
        13.10.4 Athersys, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020)
        13.10.5 Athersys, Inc. (US) Recent Development
    13.11 Betagenon AB (Sweden)
        10.11.1 Betagenon AB (Sweden) Company Details
        10.11.2 Betagenon AB (Sweden) Business Overview
        10.11.3 Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Introduction
        10.11.4 Betagenon AB (Sweden) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020)
        10.11.5 Betagenon AB (Sweden) Recent Development
    13.12 miRagen Therapeutics, Inc. (US)
        10.12.1 miRagen Therapeutics, Inc. (US) Company Details
        10.12.2 miRagen Therapeutics, Inc. (US) Business Overview
        10.12.3 miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Introduction
        10.12.4 miRagen Therapeutics, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020)
        10.12.5 miRagen Therapeutics, Inc. (US) Recent Development
    13.13 Multi Gene Vascular Systems Ltd (Israel)
        10.13.1 Multi Gene Vascular Systems Ltd (Israel) Company Details
        10.13.2 Multi Gene Vascular Systems Ltd (Israel) Business Overview
        10.13.3 Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Introduction
        10.13.4 Multi Gene Vascular Systems Ltd (Israel) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020)
        10.13.5 Multi Gene Vascular Systems Ltd (Israel) Recent Development
    13.14 ViroMed Co. Ltd. (Korea)
        10.14.1 ViroMed Co. Ltd. (Korea) Company Details
        10.14.2 ViroMed Co. Ltd. (Korea) Business Overview
        10.14.3 ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Introduction
        10.14.4 ViroMed Co. Ltd. (Korea) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020)
        10.14.5 ViroMed Co. Ltd. (Korea) Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Disclaimer
    15.3 Author Details

List of Tables Table 1. Peripheral Arterial Disease (PAD) Therapeutics Key Market Segments Table 2. Key Players Covered: Ranking by Peripheral Arterial Disease (PAD) Therapeutics Revenue Table 3. Ranking of Global Top Peripheral Arterial Disease (PAD) Therapeutics Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Anti-Platelet Drugs Table 6. Key Players of Dual Antiplatelet Therapy Drugs Table 7. Key Players of Others Table 8. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 9. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026 Table 10. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Regions (2015-2020) (US$ Million) Table 11. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Regions (2015-2020) Table 12. Global Peripheral Arterial Disease (PAD) Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 13. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Regions (2021-2026) Table 14. Market Top Trends Table 15. Key Drivers: Impact Analysis Table 16. Key Challenges Table 17. Peripheral Arterial Disease (PAD) Therapeutics Market Growth Strategy Table 18. Main Points Interviewed from Key Peripheral Arterial Disease (PAD) Therapeutics Players Table 19. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue by Players (2015-2020) (Million US$) Table 20. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Players (2015-2020) Table 21. Global Top Peripheral Arterial Disease (PAD) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peripheral Arterial Disease (PAD) Therapeutics as of 2019) Table 22. Global Peripheral Arterial Disease (PAD) Therapeutics by Players Market Concentration Ratio (CR5 and HHI) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Peripheral Arterial Disease (PAD) Therapeutics Product Solution and Service Table 25. Date of Enter into Peripheral Arterial Disease (PAD) Therapeutics Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2015-2020) (Million US$) Table 28. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Type (2015-2020) Table 29. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Type (2021-2026) Table 30. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Application (2015-2020) Table 31. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2015-2020) (Million US$) Table 32. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Application (2021-2026) Table 33. North America Key Players Peripheral Arterial Disease (PAD) Therapeutics Revenue (2019-2020) (Million US$) Table 34. North America Key Players Peripheral Arterial Disease (PAD) Therapeutics Market Share (2019-2020) Table 35. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2015-2020) (Million US$) Table 36. North America Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type (2015-2020) Table 37. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2015-2020) (Million US$) Table 38. North America Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2015-2020) Table 39. Europe Key Players Peripheral Arterial Disease (PAD) Therapeutics Revenue (2019-2020) (Million US$) Table 40. Europe Key Players Peripheral Arterial Disease (PAD) Therapeutics Market Share (2019-2020) Table 41. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2015-2020) (Million US$) Table 42. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type (2015-2020) Table 43. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2015-2020) (Million US$) Table 44. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2015-2020) Table 45. China Key Players Peripheral Arterial Disease (PAD) Therapeutics Revenue (2019-2020) (Million US$) Table 46. China Key Players Peripheral Arterial Disease (PAD) Therapeutics Market Share (2019-2020) Table 47. China Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2015-2020) (Million US$) Table 48. China Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type (2015-2020) Table 49. China Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2015-2020) (Million US$) Table 50. China Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2015-2020) Table 51. Japan Key Players Peripheral Arterial Disease (PAD) Therapeutics Revenue (2019-2020) (Million US$) Table 52. Japan Key Players Peripheral Arterial Disease (PAD) Therapeutics Market Share (2019-2020) Table 53. Japan Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2015-2020) (Million US$) Table 54. Japan Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type (2015-2020) Table 55. Japan Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2015-2020) (Million US$) Table 56. Japan Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2015-2020) Table 57. Southeast Asia Key Players Peripheral Arterial Disease (PAD) Therapeutics Revenue (2019-2020) (Million US$) Table 58. Southeast Asia Key Players Peripheral Arterial Disease (PAD) Therapeutics Market Share (2019-2020) Table 59. Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2015-2020) (Million US$) Table 60. Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type (2015-2020) Table 61. Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2015-2020) (Million US$) Table 62. Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2015-2020) Table 63. India Key Players Peripheral Arterial Disease (PAD) Therapeutics Revenue (2019-2020) (Million US$) Table 64. India Key Players Peripheral Arterial Disease (PAD) Therapeutics Market Share (2019-2020) Table 65. India Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2015-2020) (Million US$) Table 66. India Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type (2015-2020) Table 67. India Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2015-2020) (Million US$) Table 68. India Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2015-2020) Table 69. Central & South America Key Players Peripheral Arterial Disease (PAD) Therapeutics Revenue (2019-2020) (Million US$) Table 70. Central & South America Key Players Peripheral Arterial Disease (PAD) Therapeutics Market Share (2019-2020) Table 71. Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2015-2020) (Million US$) Table 72. Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type (2015-2020) Table 73. Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2015-2020) (Million US$) Table 74. Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2015-2020) Table 75. AstraZeneca Plc. (UK) Company Details Table 76. AstraZeneca Plc. (UK) Business Overview Table 77. AstraZeneca Plc. (UK) Product Table 78. AstraZeneca Plc. (UK) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020) (Million US$) Table 79. AstraZeneca Plc. (UK) Recent Development Table 80. Bayer HealthCare Pharmaceuticals (Germany) Company Details Table 81. Bayer HealthCare Pharmaceuticals (Germany) Business Overview Table 82. Bayer HealthCare Pharmaceuticals (Germany) Product Table 83. Bayer HealthCare Pharmaceuticals (Germany) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020) (Million US$) Table 84. Bayer HealthCare Pharmaceuticals (Germany) Recent Development Table 85. Bristol-Myers Squibb Company (US) Company Details Table 86. Bristol-Myers Squibb Company (US) Business Overview Table 87. Bristol-Myers Squibb Company (US) Product Table 88. Bristol-Myers Squibb Company (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020) (Million US$) Table 89. Bristol-Myers Squibb Company (US) Recent Development Table 90. Merck & Co., Inc. (US) Company Details Table 91. Merck & Co., Inc. (US) Business Overview Table 92. Merck & Co., Inc. (US) Product Table 93. Merck & Co., Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020) (Million US$) Table 94. Merck & Co., Inc. (US) Recent Development Table 95. Proteon Therapeutics, Inc. (US) Company Details Table 96. Proteon Therapeutics, Inc. (US) Business Overview Table 97. Proteon Therapeutics, Inc. (US) Product Table 98. Proteon Therapeutics, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020) (Million US$) Table 99. Proteon Therapeutics, Inc. (US) Recent Development Table 100. Sanofi S.A. (France) Company Details Table 101. Sanofi S.A. (France) Business Overview Table 102. Sanofi S.A. (France) Product Table 103. Sanofi S.A. (France) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020) (Million US$) Table 104. Sanofi S.A. (France) Recent Development Table 105. Symic Bio, Inc. (US) Company Details Table 106. Symic Bio, Inc. (US) Business Overview Table 107. Symic Bio, Inc. (US) Product Table 108. Symic Bio, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020) (Million US$) Table 109. Symic Bio, Inc. (US) Recent Development Table 110. TheraVasc Inc. (US) Business Overview Table 111. TheraVasc Inc. (US) Product Table 112. TheraVasc Inc. (US) Company Details Table 113. TheraVasc Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020) (Million US$) Table 114. TheraVasc Inc. (US) Recent Development Table 115. AnGes MG, Inc. (Japan) Company Details Table 116. AnGes MG, Inc. (Japan) Business Overview Table 117. AnGes MG, Inc. (Japan) Product Table 118. AnGes MG, Inc. (Japan) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020) (Million US$) Table 119. AnGes MG, Inc. (Japan) Recent Development Table 120. Athersys, Inc. (US) Company Details Table 121. Athersys, Inc. (US) Business Overview Table 122. Athersys, Inc. (US) Product Table 123. Athersys, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020) (Million US$) Table 124. Athersys, Inc. (US) Recent Development Table 125. Betagenon AB (Sweden) Company Details Table 126. Betagenon AB (Sweden) Business Overview Table 127. Betagenon AB (Sweden) Product Table 128. Betagenon AB (Sweden) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020) (Million US$) Table 129. Betagenon AB (Sweden) Recent Development Table 130. miRagen Therapeutics, Inc. (US) Company Details Table 131. miRagen Therapeutics, Inc. (US) Business Overview Table 132. miRagen Therapeutics, Inc. (US) Product Table 133. miRagen Therapeutics, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020) (Million US$) Table 134. miRagen Therapeutics, Inc. (US) Recent Development Table 135. Multi Gene Vascular Systems Ltd (Israel) Company Details Table 136. Multi Gene Vascular Systems Ltd (Israel) Business Overview Table 137. Multi Gene Vascular Systems Ltd (Israel) Product Table 138. Multi Gene Vascular Systems Ltd (Israel) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020) (Million US$) Table 139. Multi Gene Vascular Systems Ltd (Israel) Recent Development Table 140. ViroMed Co. Ltd. (Korea) Company Details Table 141. ViroMed Co. Ltd. (Korea) Business Overview Table 142. ViroMed Co. Ltd. (Korea) Product Table 143. ViroMed Co. Ltd. (Korea) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020) (Million US$) Table 144. ViroMed Co. Ltd. (Korea) Recent Development Table 145. Research Programs/Design for This Report Table 146. Key Data Information from Secondary Sources Table 147. Key Data Information from Primary Sources List of Figures Figure 1. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type: 2020 VS 2026 Figure 2. Anti-Platelet Drugs Features Figure 3. Dual Antiplatelet Therapy Drugs Features Figure 4. Others Features Figure 5. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application: 2020 VS 2026 Figure 6. Hospitals Case Studies Figure 7. Clinics Case Studies Figure 8. Others Case Studies Figure 9. Peripheral Arterial Disease (PAD) Therapeutics Report Years Considered Figure 10. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY Growth 2015-2026 (US$ Million) Figure 11. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Regions: 2020 VS 2026 Figure 12. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Regions (2021-2026) Figure 13. Porter's Five Forces Analysis Figure 14. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Players in 2019 Figure 15. Global Top Peripheral Arterial Disease (PAD) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peripheral Arterial Disease (PAD) Therapeutics as of 2019 Figure 16. The Top 10 and 5 Players Market Share by Peripheral Arterial Disease (PAD) Therapeutics Revenue in 2019 Figure 17. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 19. China Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Japan Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 22. India Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Bottom-up and Top-down Approaches for This Report Figure 25. Data Triangulation Figure 26. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

New Pharmaceuticals and Healthcare Reports

Internal Neuromodulation Market Forecast 2025 | Global Report

Rising number of patients suffering from neurological disorders such as Parkinson’s, essential tremor, and primary dystonia is fueling the demand for internal neuromodulation procedures. Chronic back and leg pain associated with PVD (peripheral...

Gastrointestinal Cancer Treatment Market Size 2020-2025 | Growth Forecasts

As per credible projections, gastrointestinal cancer treatment industry is expected to register strong CAGR over 2019-2025. Rising adoption of unhealthy eating habits and increasing consumption of tobacco and alcohol have increased the pervasiveness ...

Topotecan Hydrochloride Market Trends and Research Insights by 2025

As per credible estimates, global topotecan hydrochloride market is poised to acquire commendable gains by the year 2025. Rising adoption of unhealthy and sedentary lifestyle has increased the pervasiveness of small cell lung cancer, ovarian cancer, ...

Flu Vaccine Market Share 2020-2025 | Global Industry Report

As per trusted estimates, global flu vaccine market will record substantial growth during 2020-2025. Increasing government initiatives to ensure the safety of the populace, minimal side-effects associated with influenza vaccines, improving efficacy o...

Healthcare Linen Market Size - Industry Trends Report 2025

According to reliable projections, global healthcare linen market is projected to record considerable growth during 2020-2025. Rising prevalence of various diseases including cardiovascular diseases, cancer, and arthritis along with increasing cases ...

Other Reports by QY Research

Global Fragrance Fixatives Market Insights and Forecast to 2026

Fragrance Fixatives market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Fragrance Fixatives market will be able to gain the upper hand as they use the report as a powerful resource. The segment...

Global Food Grade Liquid Silicone Rubber Market Insights and Forecast to 2026

Food Grade Liquid Silicone Rubber market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Food Grade Liquid Silicone Rubber market will be able to gain the upper hand as they use the report as a po...

Global Flexible Lighting Foils Market Insights and Forecast to 2026

Flexible Lighting Foils market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Flexible Lighting Foils market will be able to gain the upper hand as they use the report as a powerful resource. The...

Global Floor Saw Cutting Equipment Market Insights and Forecast to 2026

Floor Saw Cutting Equipment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Floor Saw Cutting Equipment market will be able to gain the upper hand as they use the report as a powerful resou...

Global Winter Sports Protection Products Market Insights and Forecast to 2026

Winter Sports Protection Products market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Winter Sports Protection Products market will be able to gain the upper hand as they use the report as a po...

Publisher: QY Research
Chat with us